Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
9,284,658
-
Share change
-
-28,095
-
Total reported value
-
$137,131,700
-
Put/Call ratio
-
5%
-
Price per share
-
$14.77
-
Number of holders
-
66
-
Value change
-
+$446,835
-
Number of buys
-
24
-
Number of sells
-
30
Institutional Holders of MERRIMACK PHARMACEUTICALS IN - COM NEW (MACK) as of Q1 2024
As of 31 Mar 2024,
MERRIMACK PHARMACEUTICALS IN - COM NEW (MACK) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,284,658 shares.
The largest 10 holders included
Western Standard LLC, Newtyn Management, LLC, ADAR1 Capital Management, LLC, BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, Madison Avenue Partners, LP, Sepio Capital, LP, Invesco Ltd., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
66
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.